招商局中国基金(00133.HK)投资华顺信安
招商局中国基金(00133.HK)公布,全资附属天正投资签订了日期为今年3月24日,并关於华顺信安的投资协议及其它相关协议,天正同意向华顺信安出资2,550万元人民币(下同),以参与其新一轮融资并获得其股权权益,及以450万元并用折扣的价格向华顺信安的创始股东购买若干华顺信安的股权权益,即天正的投资金额合计3,000万元。天正已於今年4月9日支付首期投资款,共计2,400万元。
华顺信安专注於安全大数据、网络空间测绘领域,并主要从事网络资讯安全领域的技术和产品研发工作,为国家网络安全提供技术支援,为政企使用者提供网络资讯安全防护服务。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.